Rie Horii

Rie Horii

UNVERIFIED PROFILE

Are you Rie Horii?   Register this Author

Register author
Rie Horii

Rie Horii

Publications by authors named "Rie Horii"

Are you Rie Horii?   Register this Author

74Publications

1116Reads

30Profile Views

Characteristics of adverse events of endocrine therapies among older patients with breast cancer.

Support Care Cancer 2019 Oct 7;27(10):3813-3822. Epub 2019 Feb 7.

Breast Oncology Center, Cancer Institute Hospital, Ariake 3-8-31, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-019-04674-8DOI Listing
October 2019

Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence.

Radiat Oncol 2019 Sep 2;14(1):159. Epub 2019 Sep 2.

Department of Breast Surgical Oncology, Breast Oncology Center, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13014-019-1367-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720389PMC
September 2019

Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities.

Breast Cancer 2019 Aug 12. Epub 2019 Aug 12.

Breast Oncology Center, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-01003-zDOI Listing
August 2019

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.

Breast Cancer 2019 Apr 12. Epub 2019 Apr 12.

Division of Clinical Genetic Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-00971-6DOI Listing
April 2019

A diagnostic strategy for breast calcifications based on a long-term follow-up of 615 lesions.

Jpn J Radiol 2019 Mar 19;37(3):237-244. Epub 2018 Dec 19.

Breast Oncology Center, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11604-018-0803-7
Publisher Site
http://dx.doi.org/10.1007/s11604-018-0803-7DOI Listing
March 2019

Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.

Breast Cancer 2018 May 28;25(3):268-274. Epub 2017 Nov 28.

Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12282-017-0822-8
Publisher Site
http://dx.doi.org/10.1007/s12282-017-0822-8DOI Listing
May 2018

Pattern of Tumor Shrinkage during Neoadjuvant Chemotherapy Is Associated with Prognosis in Low-Grade Luminal Early Breast Cancer.

Radiology 2018 01 24;286(1):49-57. Epub 2017 Jul 24.

From the Department of Breast Medical Oncology, Breast Oncology Center (I.F., K.A., K.K., T.S., Y.I.), Department of Medical Oncology (S.T.), Department of Diagnostic Imaging (N.G., Y.K., K.O.), Department of Pathology (R.H., F.A.), Department of Breast Surgical Oncology, Breast Oncology Center (T.I.), Breast Oncology Center (S.O.), and Department of Hematology and Oncology (K.H.), the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan; and Department of Gastrointestinal Surgery, Jichi Medical University, Shimotsuke, Japan (N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017161548DOI Listing
January 2018

Inter-observer agreement among pathologists in grading the pathological response to neoadjuvant chemotherapy in breast cancer.

Breast Cancer 2018 Jan 30;25(1):118-125. Epub 2017 Aug 30.

Diagnostic Pathology Section, Clinical Laboratory Division, National Cancer Center Hospital, 5-1-1, Tuskiji, Chuo-Ku, Tokyo, 104-0045, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-017-0799-3DOI Listing
January 2018

First report of eribulin in combination with pertuzumab and trastuzumab for advanced HER2-positive breast cancer.

Breast 2017 Oct 27;35:78-84. Epub 2017 Jun 27.

Breast Medical Oncology, The Cancer Institute Hospital Ariake of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan; Breast Oncology Center, The Cancer Institute Hospital Ariake of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2017.06.015DOI Listing
October 2017

Histological assessment of therapeutic response in breast cancer.

Breast Cancer 2016 Jul 31;23(4):540-5. Epub 2013 Oct 31.

Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-013-0499-6DOI Listing
July 2016

Impact of immunohistological subtypes on the long-term prognosis of patients with metastatic breast cancer.

Surg Today 2016 Jul 14;46(7):821-6. Epub 2015 Oct 14.

Department of Hematology and Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00595-015-1252-xDOI Listing
July 2016

Therapeutic effect of taxanes on metastatic breast cancer of various immunohistochemical subtypes.

Oncol Lett 2016 Jul 25;12(1):663-669. Epub 2016 May 25.

Department of Breast Medical Oncology, Breast Oncology Center, The Cancer Institute Hospital of The Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907289PMC
July 2016

Efficacy of fulvestrant 500 mg in Japanese postmenopausal advanced/recurrent breast cancer patients and factors associated with prolonged time-to-treatment failure.

Expert Opin Pharmacother 2015 11;16(17):2561-8. Epub 2015 Nov 11.

b Breast Oncology Center , The Cancer Institute Hospital, Japanese Foundation for Cancer Research , Tokyo , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1107042DOI Listing
June 2016

The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition.

Breast Cancer 2016 May 25;23(3):391-9. Epub 2016 Feb 25.

Department of Breast and Medical Oncology, National Cancer Center Hospital East, Chiba, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-016-0675-6DOI Listing
May 2016

Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.

Breast Cancer 2016 Mar 7;23(2):318-22. Epub 2014 Nov 7.

Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-014-0576-5DOI Listing
March 2016

Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization.

Breast Cancer 2016 Jan 26;23(1):78-84. Epub 2014 Apr 26.

Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12282-014-0533-3
Publisher Site
http://dx.doi.org/10.1007/s12282-014-0533-3DOI Listing
January 2016

Prognostic significance of histological therapeutic effect in preoperative chemotherapy for breast cancer.

Pathol Int 2016 Jan 27;66(1):8-14. Epub 2015 Nov 27.

Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12365DOI Listing
January 2016

Trastuzumab Rechallenge After Lapatinib- and Trastuzumab-Resistant Disease Progression in HER2-Positive Breast Cancer.

Clin Breast Cancer 2015 Dec 18;15(6):432-9. Epub 2015 Jun 18.

Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan; Breast Oncology Center, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2015.06.002DOI Listing
December 2015

Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.

Oncotarget 2015 Oct;6(33):34892-909

Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/5408
Publisher Site
http://dx.doi.org/10.18632/oncotarget.5408DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741497PMC
October 2015

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.

BMC Cancer 2015 Oct 15;15:698. Epub 2015 Oct 15.

Department of Pathology, Cancer Institute, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1686-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607008PMC
October 2015

Non-sentinel lymph node analysis with one-step nucleic acid amplification in breast cancer patients.

Breast 2015 Aug 8;24(4):476-80. Epub 2015 May 8.

Division of Pathology, Cancer Institute of the Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2015.04.009DOI Listing
August 2015

Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics.

Int J Clin Oncol 2015 Jun 15;20(3):490-8. Epub 2014 Oct 15.

Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-014-0753-8DOI Listing
June 2015

Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination.

Pathol Int 2015 Mar 20;65(3):113-8. Epub 2015 Jan 20.

Department of Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/pin.12253DOI Listing
March 2015

Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy.

Breast Cancer 2015 Jan 12;22(1):71-8. Epub 2013 Mar 12.

Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashi-ku, Tokyo, 173-0015, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-013-0455-5DOI Listing
January 2015

The Japanese Breast Cancer Society Clinical Practice Guideline for pathological diagnosis of breast cancer.

Breast Cancer 2015 Jan 15;22(1):59-65. Epub 2014 Jul 15.

Department of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s12282-014-0549
Web Search
http://link.springer.com/content/pdf/10.1007/s12282-016-0675
Web Search
http://link.springer.com/10.1007/s12282-014-0549-8
Publisher Site
http://dx.doi.org/10.1007/s12282-014-0549-8DOI Listing
January 2015

Proportion of estrogen or progesterone receptor expressing cells in breast cancers and response to endocrine therapy.

Breast 2014 Dec 29;23(6):754-62. Epub 2014 Aug 29.

Department of Pathology, Cancer Institute, 3-8-31 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.breast.2014.08.003DOI Listing
December 2014

A clinico-pathological study on cancer in sclerosing adenosis.

Breast Cancer 2014 Nov 14;21(6):732-7. Epub 2013 Feb 14.

Division of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-013-0450-xDOI Listing
November 2014

Validation study of the UICC TNM classification of malignant tumors, seventh edition, in breast cancer.

Breast Cancer 2014 Nov 23;21(6):748-53. Epub 2013 Feb 23.

Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-013-0453-7DOI Listing
November 2014

Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer.

Breast Cancer Res Treat 2014 Nov 1;148(1):197-209. Epub 2014 Oct 1.

Beast Medical Oncology, Breast Oncology Center, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-8-31 Ariake Koto-ku, Tokyo, 135-8550, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-3148-7DOI Listing
November 2014

Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer.

Breast Cancer 2014 Sep 12;21(5):598-604. Epub 2013 Jan 12.

Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-012-0436-0DOI Listing
September 2014

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.

Cancer Sci 2014 May 26;105(5):576-82. Epub 2014 Mar 26.

Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/cas.12381
Publisher Site
http://dx.doi.org/10.1111/cas.12381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317837PMC
May 2014

Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study.

Cancer Sci 2013 Nov 6;104(11):1539-43. Epub 2013 Sep 6.

Department of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12245DOI Listing
November 2013

Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis.

Histopathology 2013 Oct 14;63(4):509-19. Epub 2013 Aug 14.

Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan; Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12172DOI Listing
October 2013

Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes.

Eur J Cancer 2013 Apr 19;49(6):1187-95. Epub 2012 Dec 19.

Division of Pathology, The Cancer Institute of Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.11.022DOI Listing
April 2013

Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis.

Cancer Sci 2013 Apr 29;104(4):453-7. Epub 2013 Jan 29.

Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12095DOI Listing
April 2013

Clear cell sarcoma of the neck which metastasized to the mammary gland.

Case Rep Oncol 2013 Jan 22;6(1):55-61. Epub 2013 Jan 22.

Department of Breast Medical Oncology, the Cancer Institute Hospital of the Japanese Foundation for Cancer Research, and the Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000345843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573807PMC
January 2013

Breast cancer associated with mammary hamartoma.

Breast Cancer 2012 Apr 6;19(2):183-6. Epub 2009 Aug 6.

Department of Breast Surgery, Cancer Institute Hospital, Koto-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-009-0147-3DOI Listing
April 2012

Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy.

Breast Cancer 2012 Feb 4. Epub 2012 Feb 4.

Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35-2 Sakaecho, Itabashi-ku, Tokyo, 173-0015, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-012-0337-2DOI Listing
February 2012

Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma.

Pathol Int 2011 Dec 31;61(12):731-6. Epub 2011 Oct 31.

Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1827.2011.02735.xDOI Listing
December 2011

Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer.

Cancer Sci 2011 Jan 30;102(1):130-6. Epub 2010 Sep 30.

Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research Breast Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1349-7006.2010.01740.xDOI Listing
January 2011

Apocrine metaplasia of breast cancer: clinicopathological features and predicting response.

Breast Cancer 2010 Oct 30;17(4):290-7. Epub 2009 Sep 30.

Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-009-0178-9DOI Listing
October 2010

High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy.

J Cancer Res Clin Oncol 2010 Sep 9;136(9):1431-8. Epub 2010 Feb 9.

Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3-8-31, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-010-0798-7DOI Listing
September 2010

Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications.

Hum Pathol 2010 May 12;41(5):679-85. Epub 2010 Feb 12.

Department of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2009.10.009DOI Listing
May 2010

Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy.

J Cancer Res Clin Oncol 2010 Feb 14;136(2):233-41. Epub 2009 Aug 14.

Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3-10-6, Ariake, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-009-0654-9DOI Listing
February 2010

Therapeutic strategies for breast cancer based on histological type.

Breast Cancer 2009 29;16(3):168-72. Epub 2009 May 29.

Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-009-0126-8DOI Listing
October 2009

Carcinoma in a solitary intraductal papilloma of the breast.

Pathol Int 2009 Mar;59(3):185-7

Department of Pathology, Cancer Institute Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1827.2009.02348.xDOI Listing
March 2009

Histogenesis of metaplastic breast carcinoma and axillary nodal metastases.

Pathol Int 2009 Feb;59(2):116-20

Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1827.2008.02339.xDOI Listing
February 2009

Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.

J Clin Oncol 2008 Aug;26(22):3727-34

Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.2968DOI Listing
August 2008

Histological features of breast cancer, highly sensitive to chemotherapy.

Breast Cancer 2007 ;14(4):393-400

Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto-ku, Tokyo, 135-8550, Japan.

View Article

Download full-text PDF

Source
January 2008

Assessment of hormone receptor status in breast cancer.

Pathol Int 2007 Dec;57(12):784-90

Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1827.2007.02174.xDOI Listing
December 2007

[Histological features of breast cancer as predictive factors for chemotherapy].

Nihon Rinsho 2007 Jun;65 Suppl 6:160-4

Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research.

View Article

Download full-text PDF

Source
June 2007

[Evaluation of hormone receptor in breast cancers and the prognosis].

Nihon Rinsho 2007 Jun;65 Suppl 6:555-8

Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research.

View Article

Download full-text PDF

Source
June 2007

Muco-epidermoid carcinoma of the breast.

Pathol Int 2006 Sep;56(9):549-53

Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-1827.2006.02004.xDOI Listing
September 2006

High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer.

Breast Cancer 2006 ;13(2):172-8

Department of Medical Oncology, Cancer Institute Hospital and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research.

View Article

Download full-text PDF

Source
August 2006

Present state of and problems with core needle biopsy for non-palpable breast lesions.

Breast Cancer 2006 ;13(1):32-7

Department of Breast Surgery, Cancer Institute Hospital, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
May 2006

Intraductal papilloma with bloody discharge from Montgomery's areolar tubercle examined by ductoscopy from the areola.

Breast Cancer 2006 ;13(1):104-6

Breast Pathology Section, Cancer Institute, Japanese Foundation for Cancer Research, 3-10-6, Ariake, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
May 2006

Spontaneous " healing" of breast cancer.

Breast Cancer 2005 ;12(2):140-4

Department of Breast Pathology, the Cancer Institute of the Japanese Foundation for Cancer Research, 3-10-6, Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
September 2005

A case of carcinosarcoma of the breast.

Breast Cancer 2005 ;12(2):149-53

Department of Breast Pathology, The Cancer Institute, 3-10-16 Ariake, Koto-ku, Tokyo 135-8550, Japan.

View Article

Download full-text PDF

Source
September 2005